Pharma revenue clawback risk to economy and Levelling Up
Posted on the 04 Jan 2023Populus Select, which supports growing life sciences and pharmaceutical firms to secure key personnel, has written to the Government warning that a new NHS drugs levy risks, not only deterring investment in the UK but could de-rail Levelling Up.